ScoreWhy is Hims & Hers Health, Inc. ?
1
Poor Management Efficiency with a low ROE of 6.19%
- The company has been able to generate a Return on Equity (avg) of 6.19% signifying low profitability per unit of shareholders funds
2
The company has declared Positive results for the last 13 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 258.59 MM
- NET PROFIT(Q) At USD 48.74 MM has Grown at 250.11%
- ROCE(HY) Highest at 41.88%
3
With ROE of 30.96%, it has a fair valuation with a 22.96 Price to Book Value
- Over the past year, while the stock has generated a return of 25.11%, its profits have risen by 5447.8% ; the PEG ratio of the company is 0
4
Consistent Returns over the last 3 years
- Along with generating 25.11% returns in the last 1 year, the stock has outperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Hims & Hers Health, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Hims & Hers Health, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Hims & Hers Health, Inc.
-30.07%
0.70
106.00%
S&P 500
14.9%
0.70
20.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
366.61%
EBIT Growth (5y)
115.69%
EBIT to Interest (avg)
-19.41
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.58
Sales to Capital Employed (avg)
2.47
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
10.04%
ROE (avg)
6.19%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
9.76
EV to EBIT
45.64
EV to EBITDA
34.52
EV to Capital Employed
6.50
EV to Sales
2.72
PEG Ratio
0.63
Dividend Yield
NA
ROCE (Latest)
14.24%
ROE (Latest)
27.23%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 321.69 MM
CASH AND EQV(HY)
Highest at USD 1,774.36 MM
NET SALES(Q)
Highest at USD 598.98 MM
-11What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at 84.04 %
RAW MATERIAL COST(Y)
Grown by 9.59% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 96.33 times
OPERATING PROFIT MARGIN(Q)
Lowest at 5.98 %
NET PROFIT(Q)
Lowest at USD 29.77 MM
EPS(Q)
Lowest at USD 0.06
Here's what is working for Hims & Hers Health, Inc.
Operating Cash Flow
Highest at USD 321.69 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 598.98 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Sales
At USD 598.98 MM has Grown at 49.16%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Cash and Eqv
Highest at USD 1,774.36 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Depreciation
Highest at USD 17.67 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Depreciation
At USD 17.67 MM has Grown at 68.84%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (USD MM)
Here's what is not working for Hims & Hers Health, Inc.
Net Profit
At USD 29.77 MM has Fallen at -61.06%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Debt-Equity Ratio
Highest at 84.04 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Operating Profit Margin
Lowest at 5.98 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Net Profit
Lowest at USD 29.77 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD 0.06
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Debtors Turnover Ratio
Lowest at 96.33 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 9.59% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Non Operating Income
Highest at USD 0.66 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
